InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (2 ops.)
Insider track record
Board DirectorDisclosed buys
1
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by McLoughlin Margaret, Director. Director active across 2 companies, notably Cortexyme, Inc.. Aggregated, 7 disclosures have been logged. Breakdown: 1 buy · 2 sells. Total volume traded: €27k. Activity tracked since 28 June 2021. The latest transaction was disclosed on 8 August 2023 (Acquisition). Regulator: SEC (Form 4). All data is free.
Declarations7 total
8,000 shares@ US$1.23100.0% of flowCommon StockSEC:0001209191-23-045231:0
Ideal exit: 4 May 2024 (T+270)
1,000 shares@ US$17.006.7% of flowCommon StockSEC:0001209191-21-060264:0
1,000 shares@ US$17.006.7% of flowCommon StockSEC:0001209191-21-060264
6,000 shares@ US$17.0039.2% of flowCommon StockSEC:0001209191-21-052285:0
6,000 shares@ US$17.0039.2% of flowCommon StockSEC:0001209191-21-052285
200 shares@ US$55.014.2% of flowCommon StockSEC:0001209191-21-043707
200 shares@ US$55.014.2% of flowCommon StockSEC:0001209191-21-043707:0
7 of 7 declarations
About McLoughlin Margaret
McLoughlin Margaret is a Board Member at Cortexyme, Inc. She participates in the governance of the company and strategic decision-making, contributing to its development in the biotechnology sector.
